-
Medicinical Cannabis made in Germany

Eurox Pharma manufactures cannabis-based medicines and products in a state-of-the-art facility in Germany. The company relies on cutting-edge research and complies with the highest pharmaceutical quality and safety standards in Germany and the EU for operations and products.
-
Successful Start of Eurox’s Dronabinol Sales

Sales of Δ9-THC represents a new revenue stream for Eurox, which follows the distribution agreement of Eurox’s full-spectrum extracts to pharmacies during the previous calendar quarter.
-
Royal Society of Medicine: Pain and cannabis medicines conference – everything you wanted to know but were too afraid to ask

Experts in the field of medical cannabis, including Eurox Group’s very own Mike Kindrat present at the Royal Society of Medicine.
-
Scots ex-banker heads firm specialising in cannabis products to treat chronic pain

Neil Smith, 56, is the chairman of Germany-based firm Eurox Pharma and CEO of the Integro Medical Clinic.
-
Cannabisextrakte Made in Germany

When it comes to the local supply of medicinal cannabis, one is mainly used to the names that one knows from looking across the Atlantic. As a European company, Eurox Pharma relies on cannabis extracts made in Germany to conquer the European market.
-
State Secretary Dr. Michael Meister visits the Eurox Pharma production plant

During the appointment, which lasted just under two hours, the two Eurox managing directors David Reckeweg-Lecompte and Dr. Bernhard Babel explained the special role of science in patient care with medical cannabis and the quality requirements that must be met. Eurox Pharma has entered into a production partnership with Dr. Reckeweg & Co. GmbH, which…
-
Eurox To Launch First ‘Made In Germany’ Cannabis Derivatives Into The Domestic Market

THE first home-made medical cannabis products will debut on the German market within weeks. This comes as Eurox Group – the producer of the derivatives range – has secured €3m growth capital from leading UK cannabis investors Fast Forward Innovations.
-
Potential of cannabis medicine

Cannabis medicine offers particular potential to improve patient care in Germany. The member of the Bundestag of Bündnis 90/Die Grünen, Daniela Wagner, and the two managing directors of Eurox Pharma, David Reckeweg-Lecompte and Dr. Bernhard Babel, agreed on this.
-
New investment – European medical cannabis company

FastForward Innovations Ltd, is pleased to announce that it has invested €3 million in Eurox Group.
-
Eurox Pharma Leadership Team to Participate as Keynote Speaker at Cannabis

Eurox Pharma is pleased to announce that it has been invited to speak at the Cannabis Business Europe 2021 in Frankfurt, Germany.







